List of Chapters/Sections(Table Of Content)
1 Intravitreal Injectable Market Overview
1.1 Product Overview and Scope of Intravitreal Injectable
1.2 Intravitreal Injectable Segment by Drug
1.2.1 Global Intravitreal Injectable Sales Growth Rate Comparison by Drug (2021-2027)
1.2.2 Anti-VEGF
1.2.3 Steroids
1.2.4 Others
1.3 Intravitreal Injectable Segment by Disease
1.3.1 Global Intravitreal Injectable Sales Comparison by Disease: (2021-2027)
1.3.2 Macular Degeneration
1.3.3 Macular Edema
1.3.4 Uveitis
1.3.5 Retinal Vein Occlusion
1.3.6 Others
1.4 Global Intravitreal Injectable Market Size Estimates and Forecasts
1.4.1 Global Intravitreal Injectable Revenue 2016-2027
1.4.2 Global Intravitreal Injectable Sales 2016-2027
1.4.3 Intravitreal Injectable Market Size by Region: 2016 Versus 2021 Versus 2027
2 Intravitreal Injectable Market Competition by Manufacturers
2.1 Global Intravitreal Injectable Sales Market Share by Manufacturers (2016-2021)
2.2 Global Intravitreal Injectable Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Intravitreal Injectable Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Intravitreal Injectable Manufacturing Sites, Area Served, Product Type
2.5 Intravitreal Injectable Market Competitive Situation and Trends
2.5.1 Intravitreal Injectable Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Intravitreal Injectable Players Market Share by Revenue
2.5.3 Global Intravitreal Injectable Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Intravitreal Injectable Retrospective Market Scenario by Region
3.1 Global Intravitreal Injectable Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Intravitreal Injectable Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Intravitreal Injectable Market Facts & Figures by Country
3.3.1 North America Intravitreal Injectable Sales by Country
3.3.2 North America Intravitreal Injectable Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Intravitreal Injectable Market Facts & Figures by Country
3.4.1 Europe Intravitreal Injectable Sales by Country
3.4.2 Europe Intravitreal Injectable Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Intravitreal Injectable Market Facts & Figures by Region
3.5.1 Asia Pacific Intravitreal Injectable Sales by Region
3.5.2 Asia Pacific Intravitreal Injectable Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Intravitreal Injectable Market Facts & Figures by Country
3.6.1 Latin America Intravitreal Injectable Sales by Country
3.6.2 Latin America Intravitreal Injectable Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Intravitreal Injectable Market Facts & Figures by Country
3.7.1 Middle East and Africa Intravitreal Injectable Sales by Country
3.7.2 Middle East and Africa Intravitreal Injectable Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Intravitreal Injectable Historic Market Analysis by Drug
4.1 Global Intravitreal Injectable Sales Market Share by Drug (2016-2021)
4.2 Global Intravitreal Injectable Revenue Market Share by Drug (2016-2021)
4.3 Global Intravitreal Injectable Price by Drug (2016-2021)
5 Global Intravitreal Injectable Historic Market Analysis by Disease
5.1 Global Intravitreal Injectable Sales Market Share by Disease (2016-2021)
5.2 Global Intravitreal Injectable Revenue Market Share by Disease (2016-2021)
5.3 Global Intravitreal Injectable Price by Disease (2016-2021)
6 Key Companies Profiled
6.1 Regeneron Pharmaceuticals (Eylea)
6.1.1 Regeneron Pharmaceuticals (Eylea) Corporation Information
6.1.2 Regeneron Pharmaceuticals (Eylea) Description and Business Overview
6.1.3 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Product Portfolio
6.1.5 Regeneron Pharmaceuticals (Eylea) Recent Developments/Updates
6.2 Allergan
6.2.1 Allergan Corporation Information
6.2.2 Allergan Description and Business Overview
6.2.3 Allergan Intravitreal Injectable Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Allergan Intravitreal Injectable Product Portfolio
6.2.5 Allergan Recent Developments/Updates
6.3 EyePoint Pharmaceuticals
6.3.1 EyePoint Pharmaceuticals Corporation Information
6.3.2 EyePoint Pharmaceuticals Description and Business Overview
6.3.3 EyePoint Pharmaceuticals Intravitreal Injectable Sales, Revenue and Gross Margin (2016-2021)
6.3.4 EyePoint Pharmaceuticals Intravitreal Injectable Product Portfolio
6.3.5 EyePoint Pharmaceuticals Recent Developments/Updates
6.4 Genentech
6.4.1 Genentech Corporation Information
6.4.2 Genentech Description and Business Overview
6.4.3 Genentech Intravitreal Injectable Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Genentech Intravitreal Injectable Product Portfolio
6.4.5 Genentech Recent Developments/Updates
6.5 Kanghong Pharmaceutical
6.5.1 Kanghong Pharmaceutical Corporation Information
6.5.2 Kanghong Pharmaceutical Description and Business Overview
6.5.3 Kanghong Pharmaceutical Intravitreal Injectable Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Kanghong Pharmaceutical Intravitreal Injectable Product Portfolio
6.5.5 Kanghong Pharmaceutical Recent Developments/Updates
7 Intravitreal Injectable Manufacturing Cost Analysis
7.1 Intravitreal Injectable Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Intravitreal Injectable
7.4 Intravitreal Injectable Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Intravitreal Injectable Distributors List
8.3 Intravitreal Injectable Customers
9 Intravitreal Injectable Market Dynamics
9.1 Intravitreal Injectable Industry Trends
9.2 Intravitreal Injectable Growth Drivers
9.3 Intravitreal Injectable Market Challenges
9.4 Intravitreal Injectable Market Restraints
10 Global Market Forecast
10.1 Intravitreal Injectable Market Estimates and Projections by Drug
10.1.1 Global Forecasted Sales of Intravitreal Injectable by Drug (2022-2027)
10.1.2 Global Forecasted Revenue of Intravitreal Injectable by Drug (2022-2027)
10.2 Intravitreal Injectable Market Estimates and Projections by Disease
10.2.1 Global Forecasted Sales of Intravitreal Injectable by Disease (2022-2027)
10.2.2 Global Forecasted Revenue of Intravitreal Injectable by Disease (2022-2027)
10.3 Intravitreal Injectable Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Intravitreal Injectable by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Intravitreal Injectable by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
